Clinical Trial Update: Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

View source ↗

Summary

This update reports results from the extension of the DISCOMS study, evaluating outcomes after discontinuation of disease-modifying therapies in people with Mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Colorado, Denver | Conditions: Multiple Sclerosis | Status: COMPLETED | Results posted: 2024-09-25